Hearing Loss News and Research

Latest Hearing Loss News and Research

Jacoti releases first FDA-registered medical device hearing aid application for smartphones

Jacoti releases first FDA-registered medical device hearing aid application for smartphones

Regulus' RG-012 receives orphan medicinal product designation in EU for treatment of Alport syndrome

Regulus' RG-012 receives orphan medicinal product designation in EU for treatment of Alport syndrome

GenVec reports record financial results for Q4 and fiscal year 2014

GenVec reports record financial results for Q4 and fiscal year 2014

GenVec collaborates with TheraBiologics to develop NSC-mediated cancer therapeutics

GenVec collaborates with TheraBiologics to develop NSC-mediated cancer therapeutics

Nottingham student announced winner in Dragon’s Den style contest dedicated to improve bus journeys for disabled

Nottingham student announced winner in Dragon’s Den style contest dedicated to improve bus journeys for disabled

Babies treated for CMV infection for six months have better developmental outcomes

Babies treated for CMV infection for six months have better developmental outcomes

SK Telecom unveils consumer-centric smart devices at Mobile World Congress 2015

SK Telecom unveils consumer-centric smart devices at Mobile World Congress 2015

WHO: 1.1 billion young people at risk of hearing loss due to unsafe use of personal audio devices

WHO: 1.1 billion young people at risk of hearing loss due to unsafe use of personal audio devices

Researchers reveal new understanding of pathobiology behind vestibular schwannoma

Researchers reveal new understanding of pathobiology behind vestibular schwannoma

USF researchers awarded grant to test new drug for age-related hearing loss

USF researchers awarded grant to test new drug for age-related hearing loss

Researchers discover inherited genetic variations associated with treatment-related hearing loss

Researchers discover inherited genetic variations associated with treatment-related hearing loss

Salicylates drugs reduce proliferation, viability of cultured vestibular schwannoma cells

Salicylates drugs reduce proliferation, viability of cultured vestibular schwannoma cells

Musical training in younger years can protect the brain in later life

Musical training in younger years can protect the brain in later life

Neuromod Devices, Irish Tinnitus Association announce launch of Tinnitus Awareness Week 2015

Neuromod Devices, Irish Tinnitus Association announce launch of Tinnitus Awareness Week 2015

MU researcher develops intervention to help older adults gradually adjust to hearing aids

MU researcher develops intervention to help older adults gradually adjust to hearing aids

TSRI researchers identify enzyme that produces inflammatory lipid molecules in the brain

TSRI researchers identify enzyme that produces inflammatory lipid molecules in the brain

Sex enhancement product recalled after Health Canada test finds undeclared drug ingredient

Sex enhancement product recalled after Health Canada test finds undeclared drug ingredient

Northwestern Medicine neurosurgeons use new adaptive hybrid surgery technology to treat brain tumor

Northwestern Medicine neurosurgeons use new adaptive hybrid surgery technology to treat brain tumor

Researchers find way to prevent noise-induced hearing loss

Researchers find way to prevent noise-induced hearing loss

Dantrolene drug may be effective treatment for rare form of diabetes

Dantrolene drug may be effective treatment for rare form of diabetes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.